MERCURY SYSTEMS INC (MRCY)

US5893781089 - Common Stock

31.65  +0.42 (+1.34%)

After market: 31.45 -0.2 (-0.63%)

Fundamental Rating

2

Taking everything into account, MRCY scores 2 out of 10 in our fundamental rating. MRCY was compared to 65 industry peers in the Aerospace & Defense industry. The financial health of MRCY is average, but there are quite some concerns on its profitability. MRCY is valued expensive and it does not seem to be growing.



2

1. Profitability

1.1 Basic Checks

MRCY had negative earnings in the past year.
MRCY had a positive operating cash flow in the past year.
MRCY had positive earnings in 4 of the past 5 years.
The reported operating cash flow has been mixed in the past 5 years: MRCY reported negative operating cash flow in multiple years.

1.2 Ratios

With a Return On Assets value of -5.68%, MRCY is not doing good in the industry: 64.06% of the companies in the same industry are doing better.
MRCY has a Return On Equity (-9.17%) which is in line with its industry peers.
Industry RankSector Rank
ROA -5.68%
ROE -9.17%
ROIC N/A
ROA(3y)0.83%
ROA(5y)2.22%
ROE(3y)1.04%
ROE(5y)2.59%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

MRCY has a Gross Margin (22.63%) which is comparable to the rest of the industry.
MRCY's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for MRCY so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 22.63%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-10.12%
GM growth 5Y-6.62%

5

2. Health

2.1 Basic Checks

MRCY does not have a ROIC to compare to the WACC, probably because it is not profitable.
MRCY has more shares outstanding than it did 1 year ago.
MRCY has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, MRCY has a worse debt to assets ratio.

2.2 Solvency

An Altman-Z score of 1.92 indicates that MRCY is not a great score, but indicates only limited risk for bankruptcy at the moment.
MRCY has a Altman-Z score (1.92) which is in line with its industry peers.
MRCY has a Debt/Equity ratio of 0.42. This is a healthy value indicating a solid balance between debt and equity.
MRCY has a Debt to Equity ratio (0.42) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.42
Debt/FCF N/A
Altman-Z 1.92
ROIC/WACCN/A
WACC8.79%

2.3 Liquidity

MRCY has a Current Ratio of 4.58. This indicates that MRCY is financially healthy and has no problem in meeting its short term obligations.
MRCY has a Current ratio of 4.58. This is amongst the best in the industry. MRCY outperforms 87.50% of its industry peers.
MRCY has a Quick Ratio of 2.93. This indicates that MRCY is financially healthy and has no problem in meeting its short term obligations.
MRCY's Quick ratio of 2.93 is amongst the best of the industry. MRCY outperforms 87.50% of its industry peers.
Industry RankSector Rank
Current Ratio 4.58
Quick Ratio 2.93

2

3. Growth

3.1 Past

The earnings per share for MRCY have decreased strongly by -147.37% in the last year.
The Earnings Per Share has been decreasing by -6.59% on average over the past years.
The Revenue for MRCY has decreased by -16.87% in the past year. This is quite bad
MRCY shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 14.58% yearly.
EPS 1Y (TTM)-147.37%
EPS 3Y-23.99%
EPS 5Y-6.59%
EPS growth Q2Q-165%
Revenue 1Y (TTM)-16.87%
Revenue growth 3Y6.93%
Revenue growth 5Y14.58%
Revenue growth Q2Q-20.96%

3.2 Future

Based on estimates for the next years, MRCY will show a decrease in Earnings Per Share. The EPS will decrease by -1.14% on average per year.
The Revenue is expected to decrease by -0.56% on average over the next years.
EPS Next Y-161.6%
EPS Next 2Y-26.99%
EPS Next 3Y-1.14%
EPS Next 5YN/A
Revenue Next Year-18.27%
Revenue Next 2Y-6.56%
Revenue Next 3Y-0.56%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for MRCY. In the last year negative earnings were reported.
The Price/Forward Earnings ratio is 58.79, which means the current valuation is very expensive for MRCY.
The rest of the industry has a similar Price/Forward Earnings ratio as MRCY.
MRCY's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 20.20.
Industry RankSector Rank
PE N/A
Fwd PE 58.79

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-26.99%
EPS Next 3Y-1.14%

0

5. Dividend

5.1 Amount

No dividends for MRCY!.
Industry RankSector Rank
Dividend Yield N/A

MERCURY SYSTEMS INC

NASDAQ:MRCY (5/17/2024, 7:14:24 PM)

After market: 31.45 -0.2 (-0.63%)

31.65

+0.42 (+1.34%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryAerospace & Defense
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap1.88B
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 58.79
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -5.68%
ROE -9.17%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 22.63%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.35
Health
Industry RankSector Rank
Debt/Equity 0.42
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 4.58
Quick Ratio 2.93
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)-147.37%
EPS 3Y-23.99%
EPS 5Y
EPS growth Q2Q
EPS Next Y-161.6%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-16.87%
Revenue growth 3Y6.93%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y